1. Home
  2. Publications
  3. Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate...

Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle Study.

Abstract:
Differentiating aggressive clear cell renal cell carcinoma (ccRCC) from indolent lesions is challenging using conventional imaging. This work prospectively compared the metabolic imaging phenotype of renal tumors using carbon-13 MRI following injection of hyperpolarized [1-13C]pyruvate (HP-13C-MRI) and validated these findings with histopathology. Nine patients with treatment-naïve renal tumors (6 ccRCCs, 1 liposarcoma, 1 pheochromocytoma, 1 oncocytoma) underwent pre-operative HP-13C-MRI and conventional proton (1H) MRI. Multi-regional tissue samples were collected using patient-specific 3D-printed tumor molds for spatial registration between imaging and molecular analysis. The apparent exchange rate constant (kPL) between 13C-pyruvate and 13C-lactate was calculated. Immunohistochemistry for the pyruvate transporter (MCT1) from 44 multi-regional samples, as well as associations between MCT1 expression and outcome in the TCGA-KIRC dataset, were investigated. Increasing kPL in ccRCC was correlated with increasing overall tumor grade (ρ = 0.92, p = 0.009) and MCT1 expression (r = 0.89, p = 0.016), with similar results acquired from the multi-regional analysis. Conventional 1H-MRI parameters did not discriminate tumor grades. The correlation between MCT1 and ccRCC grade was confirmed within a TCGA dataset (p < 0.001), where MCT1 expression was a predictor of overall and disease-free survival. In conclusion, metabolic imaging using HP-13C-MRI differentiates tumor aggressiveness in ccRCC and correlates with the expression of MCT1, a predictor of survival. HP-13C-MRI may non-invasively characterize metabolic phenotypes within renal cancer.
Authors:
S Ursprung, R Woitek, MA McLean, AN Priest, M Crispin-Ortuzar, CR Brodie, AB Gill, M Gehrung, L Beer, ACP Riddick, J Field-Rayner, JT Grist, SS Deen, F Riemer, JD Kaggie, F Zaccagna, JAG Duarte, MJ Locke, A Frary, TF Aho, JN Armitage, R Casey, IA Mendichovszky, SJ Welsh, T Barrett, MJ Graves, T Eisen, TJ Mitchell, AY Warren, KM Brindle, E Sala, GD Stewart, FA Gallagher
Journal:
Cancers (Basel)
Citation info:
14(2)
Publication date:
11th Jan 2022
Full text
DOI